Top House Dem calls for probe into CVS-Aetna merger

Top House Dem calls for probe into CVS-Aetna merger
© Greg Nash

A top House Democrat is calling for a hearing to examine the merger between CVS and Aetna.

In a letter to House Energy and Commerce Committee chairman Greg WaldenGregory (Greg) Paul WaldenHere are the eight Republicans who voted with Democrats on the Equality Act House approves anti-LGBT discrimination Equality Act Overnight Health Care — Presented by Campaign for Accountability — House passes drug pricing bills amid ObamaCare row | Senate Republicans running away from Alabama abortion law | Ocasio-Cortez confronts CEO over K drug price tag MORE (R-Ore.), the committee’s ranking member Frank Pallone Jr.Frank Joseph PalloneThe Hill's Morning Report - Presented by Pass USMCA Coalition - Restrictive state abortion laws ignite fiery 2020 debate Work on surprise medical bills goes into overdrive Overnight Health Care — Presented by Campaign for Accountability — Alabama bill heats up fight over abortion | 2020 Dems blast bill | ACLU challenges Ohio abortion law | NC sues e-cig maker Juul | Flurry of activity on surprise medical bills MORE (D-N.J.) asked for a hearing on the merger as soon as possible.

“As the business of healthcare continues to morph, it is critical that Congress closely examine the changing relationships among healthcare entities and the impact these changing relationships have on the way healthcare is delivered in this country,” Pallone wrote.

ADVERTISEMENT

If approved, the $69 billion merger of the nation’s largest pharmacy and third-largest health insurer could have major implications for the health-care industry.

The companies are arguing that when merged, they will be able to improve health outcomes and reduce costs by integrating the pharmacy and insurer. They are promising significant changes to the business of health-care delivery.

There has been an increasing trend of insurers wanting to partner with pharmacy benefit managers, as seen by UnitedHealth’s purchase of OptumRx.

Amazon's rumored interest in entering into the pharmaceutical supply industry has loomed as a potential motivator of the merger, which Pallone noted in his request.

“Increasingly, health systems are offering health insurance and insurers are buying or partnering with health care providers,” Pallone wrote. “In addition, large corporations such as Amazon are considering pharmacy or healthcare operations, expanding their businesses in completely new directions.”